Airain Ltd’s Exact Sciences EXAS Stock Holding History

Airain Ltd’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-45,090	Closed	-$532K	–	610
2013 Q3	$532K	Buy	45,090 +32,882	+269%	+$422K	0.1%	229
2013 Q2	$170K	Buy	+12,208	New	+$133K	0.03%	488

Other funds holding EXAS

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Airain Ltd's EXAS Position: Q4 2013 in Review

Airain Ltd sold out of Exact Sciences (EXAS) in Q4 2013, closing a stake of 45,090 shares — an estimated $532K sold.

Airain Ltd first reported a position in EXAS in Q2 2013 and held it in 2 quarters. The position peaked at $532K in Q3 2013. 131 funds tracked by Wall St. Rank hold EXAS as of Q4 2013.

Airain Ltd reported no remaining Exact Sciences position as of Q4 2013 after selling out during the quarter.
Airain Ltd sold 45,090 Exact Sciences shares in Q4 2013, an estimated $532K.
Airain Ltd first reported a position in Exact Sciences in Q2 2013 and held it in 2 quarters.
Airain Ltd's Exact Sciences position peaked at $532K in Q3 2013.
131 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2013.

Based on Airain Ltd's 13F filing for Q4 2013, filed 12 Feb 2014.